XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
6 Months Ended
Jul. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurements
The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of July 31, 2022 (in thousands):

Level 1
Level 2
Total
Cash equivalents:
Money market funds$590,661 $— $590,661 
Commercial paper— 71,821 71,821 
Corporate notes and bonds— 15,696 15,696 
Short-term investments:
Corporate notes and bonds— 1,729,751 1,729,751 
Commercial paper— 889,803 889,803 
Certificates of deposit— 289,481 289,481 
U.S. government and agency securities— 137,442 137,442 
Long-term investments:
Corporate notes and bonds— 704,521 704,521 
U.S. government and agency securities— 382,163 382,163 
Total
$590,661 $4,220,678 $4,811,339 
The following table presents the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of January 31, 2022 (in thousands):

Level 1
Level 2
Total
Cash equivalents:
Money market funds$722,492 $— $722,492 
Commercial paper— 77,794 77,794 
U.S. government securities— 36,995 36,995 
Corporate notes and bonds— 7,949 7,949 
Short-term investments:
Corporate notes and bonds— 1,662,436 1,662,436 
Commercial paper— 883,636 883,636 
U.S. government and agency securities— 116,712 116,712 
Certificates of deposit— 103,580 103,580 
Long-term investments:
Corporate notes and bonds— 935,603 935,603 
U.S. government and agency securities— 320,207 320,207 
Certificates of deposit— 397 397 
Total
$722,492 $4,145,309 $4,867,801 
The following table presents the Company’s strategic investments by type (in thousands):

July 31, 2022January 31, 2022
Equity securities:
Non-marketable equity securities under Measurement Alternative$176,805 $170,860 
Marketable equity securities29,168 34,646 
Debt securities:
Non-marketable debt securities1,500 2,250 
Total strategic investments—included in other assets$207,473 $207,756 
Unrealized Gain (Loss) on Investments
The following table summarizes the unrealized gains and losses included in the carrying value of the Company’s strategic investments in equity securities held as of July 31, 2022 (in thousands):

Three Months Ended July 31,Six Months Ended July 31,
2022202120222021
Non-marketable equity securities under Measurement Alternative:
Upward adjustments$— $8,060 $— $8,060 
Impairments(26,555)— (26,555)— 
Marketable equity securities:
Net unrealized gains (losses)(1)
3,382 — (5,477)— 
Total—included in other income (expense), net$(23,173)$8,060 $(32,032)$8,060 
________________
(1)The Company did not have any strategic investments in marketable equity securities during the three and six months ended July 31, 2021.